Question
a pharmaceutical company wants to study the effectiveness of a new drug in treating migraine headaches. for its trial, uit gathers randomly selected volunteers regardless of their age, gender, or race is this an appropriate, random sample on which the pharmaceutical company can rely to draw its conclusion
answer choices:
yes, this an appropriate, random sample
no, this is not an appropriate, random sample. the company should only run the trial on female volunteers because migraine headaches are more common in women
no, this is not an appropriate, random sample. the company should only run the trial on volunteers age 50 and older
there is not enough information to determine whether this is an appropriate, random sample for the population in this scenario
answer choices:
yes, this an appropriate, random sample
no, this is not an appropriate, random sample. the company should only run the trial on female volunteers because migraine headaches are more common in women
no, this is not an appropriate, random sample. the company should only run the trial on volunteers age 50 and older
there is not enough information to determine whether this is an appropriate, random sample for the population in this scenario
Answers
GPT-4o mini
The best answer in this context is:
**there is not enough information to determine whether this is an appropriate, random sample for the population in this scenario.**
While the company has gathered volunteers randomly, we cannot ascertain if this sample adequately represents the broader population of migraine sufferers without more information on the population's demographics and how they relate to the efficacy of the drug. Migraine characteristics (including prevalence rates by age, gender, and race) could influence study outcomes and effectiveness, suggesting that some stratification may be necessary for more meaningful results.
**there is not enough information to determine whether this is an appropriate, random sample for the population in this scenario.**
While the company has gathered volunteers randomly, we cannot ascertain if this sample adequately represents the broader population of migraine sufferers without more information on the population's demographics and how they relate to the efficacy of the drug. Migraine characteristics (including prevalence rates by age, gender, and race) could influence study outcomes and effectiveness, suggesting that some stratification may be necessary for more meaningful results.